Table 1. Details of Patients at... | American Society of Hematology

Table 1.

Details of Patients at Autografting, Outcome, and Survival

Patients	Age/ Sex	Sokal Index	Interval Diagnosis to Autografting (mo)	Mobilizing Therapy	Cytogenetics on HPC Preautografting (Ph-positive/metas)	HighDose Therapy	Marrow Cytogenetics Ph-Positive (%)	Outcome	BCR-ABL/ABL Ratio	Follow-up From ASCT (mo)
TP	59/F	1.05	6	ICE	0/126	IVT	0	A/Ph⁺ 100%		76
BG	46/M	1.45	17	ICE	0/119	IVT	0	Died of BC disease		29
BF1	44/F	0.75	30	ICE	0/119	BU	0	A/Ph⁺ 46%		42
BC	53/F	0.71	10	ICE	0/87	IVT	4	A/Ph⁺ 10%		48
BP	37/M	0.77	7	ICE	0/75	IVT	0	A/Ph⁺ 100%		48
MC1	48/F	0.85	6	ICE	0/30	IVT	15	A/Ph⁺ 26%		48
SE1	40/M	0.79	5	ICE	0/178	BU	0	Alive, in CCR	<0.001	44
GR	47/M	0.91	9	ICE	0/114	IVT	30	Died of BC disease		18
VG1	39/M	0.87	4	ICE	0/137	BU	0	Alive, in CCR	0.003	41
GO	46/M	0.66	9	ICE	0/128	BU	5	A/Ph⁺ 50%		39
SS	60/M	0.84	6	mini-ICE	17/285	BU	0	A/Ph⁺ 65%		31
UK	49/F	0.65	5	ICE	14/203	BU	0	A/Ph⁺ 85%		36
PN	30/M	1.43	14	mini-ICE	0/178	BU	0	A/Ph⁺ 100%/BC		25
PG	56/M	3.03	4	mini-ICE	0/59	BU	0	A/Ph⁺ 100%		26
BS	22/F	0.51	8	mini-ICE	12/124	BU	100	A/Ph⁺ 100%		23
NF	57/M	1	3	mini-ICE	13/106	BU	25	A/Ph⁺ 29%		26
DG	41/M	0.68	5	mini-ICE	0/42	BU	0	Alive, in CCR	0.002	24
CE	62/M	0.92	6	mini-ICE	0/40	BU	20	A/Ph⁺ 20%		23
GG	27/M	1.03	5	mini-ICE	0/100	BU	0	Alive, in CCR	0.002	21
PL	37/F	1.35	6	mini-ICE	0/88	BU	5	A/Ph⁺ 20%		19
MA	42/M	0.59	4	mini-ICE	7/51	BU	30	A/Ph⁺ 12%		21
BM	34/M	1.69	4	mini-ICE	65/176	BU	95	A/Ph⁺ 58%		18
PM	46/M	0.614	3	mini-ICE	0/248	BU	0	Alive, in CCR	0.001	19
CR	48/M	0.63	7	mini-ICE	0/69	BU	0	Alive, in CCR	0.01	15
SP	32/M	1.0	11	mini-ICE	0/35	BU	0	Alive, in CCR	0.01	7
MM	52/M	0.71	6	mini-ICE	0/40	BU	6	A/Ph⁺ 6%		13
MG	45/M	1.06	4	mini-ICE	1/30	BU	90	A/Ph⁺ 90%		13
FV	34/M	0.6	7	mini-ICE	0/30	BU	0	Alive, in CCR	0.01	6
GA	49/M	0.72	14	mini-ICE	0/130	BU	40	A/Ph⁺ 46%		6
MA	47/M	0.61	3	mini-ICE	2/2	BU	10	A/Ph⁺ 10%		6

Patients	Age/ Sex	Sokal Index	Interval Diagnosis to Autografting (mo)	Mobilizing Therapy	Cytogenetics on HPC Preautografting (Ph-positive/metas)	HighDose Therapy	Marrow Cytogenetics Ph-Positive (%)	Outcome	BCR-ABL/ABL Ratio	Follow-up From ASCT (mo)
TP	59/F	1.05	6	ICE	0/126	IVT	0	A/Ph⁺ 100%		76
BG	46/M	1.45	17	ICE	0/119	IVT	0	Died of BC disease		29
BF1	44/F	0.75	30	ICE	0/119	BU	0	A/Ph⁺ 46%		42
BC	53/F	0.71	10	ICE	0/87	IVT	4	A/Ph⁺ 10%		48
BP	37/M	0.77	7	ICE	0/75	IVT	0	A/Ph⁺ 100%		48
MC1	48/F	0.85	6	ICE	0/30	IVT	15	A/Ph⁺ 26%		48
SE1	40/M	0.79	5	ICE	0/178	BU	0	Alive, in CCR	<0.001	44
GR	47/M	0.91	9	ICE	0/114	IVT	30	Died of BC disease		18
VG1	39/M	0.87	4	ICE	0/137	BU	0	Alive, in CCR	0.003	41
GO	46/M	0.66	9	ICE	0/128	BU	5	A/Ph⁺ 50%		39
SS	60/M	0.84	6	mini-ICE	17/285	BU	0	A/Ph⁺ 65%		31
UK	49/F	0.65	5	ICE	14/203	BU	0	A/Ph⁺ 85%		36
PN	30/M	1.43	14	mini-ICE	0/178	BU	0	A/Ph⁺ 100%/BC		25
PG	56/M	3.03	4	mini-ICE	0/59	BU	0	A/Ph⁺ 100%		26
BS	22/F	0.51	8	mini-ICE	12/124	BU	100	A/Ph⁺ 100%		23
NF	57/M	1	3	mini-ICE	13/106	BU	25	A/Ph⁺ 29%		26
DG	41/M	0.68	5	mini-ICE	0/42	BU	0	Alive, in CCR	0.002	24
CE	62/M	0.92	6	mini-ICE	0/40	BU	20	A/Ph⁺ 20%		23
GG	27/M	1.03	5	mini-ICE	0/100	BU	0	Alive, in CCR	0.002	21
PL	37/F	1.35	6	mini-ICE	0/88	BU	5	A/Ph⁺ 20%		19
MA	42/M	0.59	4	mini-ICE	7/51	BU	30	A/Ph⁺ 12%		21
BM	34/M	1.69	4	mini-ICE	65/176	BU	95	A/Ph⁺ 58%		18
PM	46/M	0.614	3	mini-ICE	0/248	BU	0	Alive, in CCR	0.001	19
CR	48/M	0.63	7	mini-ICE	0/69	BU	0	Alive, in CCR	0.01	15
SP	32/M	1.0	11	mini-ICE	0/35	BU	0	Alive, in CCR	0.01	7
MM	52/M	0.71	6	mini-ICE	0/40	BU	6	A/Ph⁺ 6%		13
MG	45/M	1.06	4	mini-ICE	1/30	BU	90	A/Ph⁺ 90%		13
FV	34/M	0.6	7	mini-ICE	0/30	BU	0	Alive, in CCR	0.01	6
GA	49/M	0.72	14	mini-ICE	0/130	BU	40	A/Ph⁺ 46%		6
MA	47/M	0.61	3	mini-ICE	2/2	BU	10	A/Ph⁺ 10%		6

Abbreviations: IVT, idarubicin, etoposide, TBI; BU, busulfan; ASCT, autografting; CCR, complete cytogenetic remission; BC, blastic crisis.